A new study has found that taking a small daily dose of aspirin could help stop colon cancer from returning in some patients.

Aspirin reduced colorectal cancer recurrence risk by 50% in patients with PIK3CA mutations over three years. Mutations in the PI3K pathway predict aspirin response, broadening its use to more patients ...

A randomized study has produced some hopeful news for colorectal cancer survivors with an unlikely suspect: the commonly used ...

PI3K/mTOR inhibition potentiates and extends palbociclib activity in anaplastic thyroid cancer. Endocr Relat Cancer. 2019 Apr 1;26(4):425-436. doi: 10.1530/ERC-19-0011. Epub 2019 Jan 1. PMID: 30699064 ...